The global 1-Bromopropane for Pharmaceutical Use market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

1-Bromopropane for pharmaceutical use is a high-purity 1-bromopropane product that meets pharmaceutical standards. In the pharmaceutical industry, chemicals used to synthesize drugs or pharmaceutical intermediates must meet strict purity, quality and safety standards to ensure that the final produced drugs are of stable, pure quality and comply with relevant guidelines and regulations in the pharmaceutical industry. 1-Bromopropane for pharmaceutical use usually undergoes special purification treatments to remove possible impurities, residues or other impure substances to ensure that the purity of the product meets the requirements required by the pharmaceutical industry. Only such high-purity 1-bromopropane can be safely used to synthesize drug intermediates without affecting the quality and safety of the drug. Pharmaceutical 1-bromopropane is widely used in the pharmaceutical field and is often used to synthesize various drugs, such as antibiotics, analgesics, anti-cancer drugs, etc. Its high purity and compliance with pharmaceutical standards allow pharmaceutical manufacturers to more reliably control the quality and purity of drugs during the production process, thereby ensuring the safety and effectiveness of the final product.

From a downstream perspective, Intermediate Synthesis accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

1-Bromopropane for Pharmaceutical Use leading manufacturers including Albemarle, Chemtura, ICL, Weifang Longwei, Solaris Chemtech, Longsheng Chemical, Tongcheng Medical, Shandong Moris Tech, Shenrunfa, Shouguang Fukang Pharmaceutical, etc., dominate supply; the top five capture approximately % of global revenue, with Albemarle leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global 1-Bromopropane for Pharmaceutical Use market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of 1-Bromopropane for Pharmaceutical Use Market Report

Report Metric	Details
Report Name	1-Bromopropane for Pharmaceutical Use Market
Segment by Type	99.0% 99.5% 99.9% Others
Segment by Application	Intermediate Synthesis Drug Synthesis Others
Production by Region	North America Europe China Japan
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Albemarle, Chemtura, ICL, Weifang Longwei, Solaris Chemtech, Longsheng Chemical, Tongcheng Medical, Shandong Moris Tech, Shenrunfa, Shouguang Fukang Pharmaceutical, Shouguang Luyuan Salt Chemical, Jinbiao Chemical, Nova International, Infinity Scientific, Ataman Kimya
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the 1-Bromopropane for Pharmaceutical Use study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the 1-Bromopropane for Pharmaceutical Use Market report?

Ans: The main players in the 1-Bromopropane for Pharmaceutical Use Market are Albemarle, Chemtura, ICL, Weifang Longwei, Solaris Chemtech, Longsheng Chemical, Tongcheng Medical, Shandong Moris Tech, Shenrunfa, Shouguang Fukang Pharmaceutical, Shouguang Luyuan Salt Chemical, Jinbiao Chemical, Nova International, Infinity Scientific, Ataman Kimya

What are the Application segmentation covered in the 1-Bromopropane for Pharmaceutical Use Market report?

Ans: The Applications covered in the 1-Bromopropane for Pharmaceutical Use Market report are Intermediate Synthesis, Drug Synthesis, Others

What are the Type segmentation covered in the 1-Bromopropane for Pharmaceutical Use Market report?

Ans: The Types covered in the 1-Bromopropane for Pharmaceutical Use Market report are 99.0%, 99.5%, 99.9%, Others

1 Study Coverage

1.1 Introduction to 1-Bromopropane for Pharmaceutical Use: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global 1-Bromopropane for Pharmaceutical Use Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 99.0%

1.2.3 99.5%

1.2.4 99.9%

1.2.5 Others

1.3 Market Segmentation by Application

1.3.1 Global 1-Bromopropane for Pharmaceutical Use Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Intermediate Synthesis

1.3.3 Drug Synthesis

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global 1-Bromopropane for Pharmaceutical Use Revenue Estimates and Forecasts 2020-2031

2.2 Global 1-Bromopropane for Pharmaceutical Use Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global 1-Bromopropane for Pharmaceutical Use Sales Estimates and Forecasts 2020-2031

2.4 Global 1-Bromopropane for Pharmaceutical Use Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Global Production Analysis

3.1 Global 1-Bromopropane for Pharmaceutical Use Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 North America

3.4.2 Europe

3.4.3 China

3.4.4 Japan

4 Competition by Manufacturers

4.1 Global 1-Bromopropane for Pharmaceutical Use Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global 1-Bromopropane for Pharmaceutical Use Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 99.0% Market Size by Manufacturers

4.5.2 99.5% Market Size by Manufacturers

4.5.3 99.9% Market Size by Manufacturers

4.5.4 Others Market Size by Manufacturers

4.6 Global 1-Bromopropane for Pharmaceutical Use Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

5 Global Product Segmentation Analysis

5.1 Global 1-Bromopropane for Pharmaceutical Use Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global 1-Bromopropane for Pharmaceutical Use Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

6 Global Downstream Application Analysis

6.1 Global 1-Bromopropane for Pharmaceutical Use Sales by Application

6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

6.1.2 Global Sales Market Share by Application (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global 1-Bromopropane for Pharmaceutical Use Revenue by Application

6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

6.2.2 Revenue Market Share by Application (2020-2031)

6.3 Global Pricing Dynamics by Application (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Application

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America 1-Bromopropane for Pharmaceutical Use Sales and Revenue by Type (2020-2031)

7.4 North America 1-Bromopropane for Pharmaceutical Use Sales and Revenue by Application (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America 1-Bromopropane for Pharmaceutical Use Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe 1-Bromopropane for Pharmaceutical Use Sales and Revenue by Type (2020-2031)

8.4 Europe 1-Bromopropane for Pharmaceutical Use Sales and Revenue by Application (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe 1-Bromopropane for Pharmaceutical Use Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific 1-Bromopropane for Pharmaceutical Use Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific 1-Bromopropane for Pharmaceutical Use Sales and Revenue by Application (2020-2031)

9.5 Asia-Pacific 1-Bromopropane for Pharmaceutical Use Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America 1-Bromopropane for Pharmaceutical Use Sales and Revenue by Type (2020-2031)

10.4 Central and South America 1-Bromopropane for Pharmaceutical Use Sales and Revenue by Application (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America 1-Bromopropane for Pharmaceutical Use Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa 1-Bromopropane for Pharmaceutical Use Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa 1-Bromopropane for Pharmaceutical Use Sales and Revenue by Application (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa 1-Bromopropane for Pharmaceutical Use Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

12 Corporate Profile

12.1 Albemarle

12.1.1 Albemarle Corporation Information

12.1.2 Albemarle Business Overview

12.1.3 Albemarle 1-Bromopropane for Pharmaceutical Use Product Models, Descriptions and Specifications

12.1.4 Albemarle 1-Bromopropane for Pharmaceutical Use Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 Albemarle 1-Bromopropane for Pharmaceutical Use Sales by Product in 2024

12.1.6 Albemarle 1-Bromopropane for Pharmaceutical Use Sales by Application in 2024

12.1.7 Albemarle 1-Bromopropane for Pharmaceutical Use Sales by Geographic Area in 2024

12.1.8 Albemarle 1-Bromopropane for Pharmaceutical Use SWOT Analysis

12.1.9 Albemarle Recent Developments

12.2 Chemtura

12.2.1 Chemtura Corporation Information

12.2.2 Chemtura Business Overview

12.2.3 Chemtura 1-Bromopropane for Pharmaceutical Use Product Models, Descriptions and Specifications

12.2.4 Chemtura 1-Bromopropane for Pharmaceutical Use Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 Chemtura 1-Bromopropane for Pharmaceutical Use Sales by Product in 2024

12.2.6 Chemtura 1-Bromopropane for Pharmaceutical Use Sales by Application in 2024

12.2.7 Chemtura 1-Bromopropane for Pharmaceutical Use Sales by Geographic Area in 2024

12.2.8 Chemtura 1-Bromopropane for Pharmaceutical Use SWOT Analysis

12.2.9 Chemtura Recent Developments

12.3 ICL

12.3.1 ICL Corporation Information

12.3.2 ICL Business Overview

12.3.3 ICL 1-Bromopropane for Pharmaceutical Use Product Models, Descriptions and Specifications

12.3.4 ICL 1-Bromopropane for Pharmaceutical Use Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 ICL 1-Bromopropane for Pharmaceutical Use Sales by Product in 2024

12.3.6 ICL 1-Bromopropane for Pharmaceutical Use Sales by Application in 2024

12.3.7 ICL 1-Bromopropane for Pharmaceutical Use Sales by Geographic Area in 2024

12.3.8 ICL 1-Bromopropane for Pharmaceutical Use SWOT Analysis

12.3.9 ICL Recent Developments

12.4 Weifang Longwei

12.4.1 Weifang Longwei Corporation Information

12.4.2 Weifang Longwei Business Overview

12.4.3 Weifang Longwei 1-Bromopropane for Pharmaceutical Use Product Models, Descriptions and Specifications

12.4.4 Weifang Longwei 1-Bromopropane for Pharmaceutical Use Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 Weifang Longwei 1-Bromopropane for Pharmaceutical Use Sales by Product in 2024

12.4.6 Weifang Longwei 1-Bromopropane for Pharmaceutical Use Sales by Application in 2024

12.4.7 Weifang Longwei 1-Bromopropane for Pharmaceutical Use Sales by Geographic Area in 2024

12.4.8 Weifang Longwei 1-Bromopropane for Pharmaceutical Use SWOT Analysis

12.4.9 Weifang Longwei Recent Developments

12.5 Solaris Chemtech

12.5.1 Solaris Chemtech Corporation Information

12.5.2 Solaris Chemtech Business Overview

12.5.3 Solaris Chemtech 1-Bromopropane for Pharmaceutical Use Product Models, Descriptions and Specifications

12.5.4 Solaris Chemtech 1-Bromopropane for Pharmaceutical Use Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.5.5 Solaris Chemtech 1-Bromopropane for Pharmaceutical Use Sales by Product in 2024

12.5.6 Solaris Chemtech 1-Bromopropane for Pharmaceutical Use Sales by Application in 2024

12.5.7 Solaris Chemtech 1-Bromopropane for Pharmaceutical Use Sales by Geographic Area in 2024

12.5.8 Solaris Chemtech 1-Bromopropane for Pharmaceutical Use SWOT Analysis

12.5.9 Solaris Chemtech Recent Developments

12.6 Longsheng Chemical

12.6.1 Longsheng Chemical Corporation Information

12.6.2 Longsheng Chemical Business Overview

12.6.3 Longsheng Chemical 1-Bromopropane for Pharmaceutical Use Product Models, Descriptions and Specifications

12.6.4 Longsheng Chemical 1-Bromopropane for Pharmaceutical Use Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.6.5 Longsheng Chemical Recent Developments

12.7 Tongcheng Medical

12.7.1 Tongcheng Medical Corporation Information

12.7.2 Tongcheng Medical Business Overview

12.7.3 Tongcheng Medical 1-Bromopropane for Pharmaceutical Use Product Models, Descriptions and Specifications

12.7.4 Tongcheng Medical 1-Bromopropane for Pharmaceutical Use Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.7.5 Tongcheng Medical Recent Developments

12.8 Shandong Moris Tech

12.8.1 Shandong Moris Tech Corporation Information

12.8.2 Shandong Moris Tech Business Overview

12.8.3 Shandong Moris Tech 1-Bromopropane for Pharmaceutical Use Product Models, Descriptions and Specifications

12.8.4 Shandong Moris Tech 1-Bromopropane for Pharmaceutical Use Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.8.5 Shandong Moris Tech Recent Developments

12.9 Shenrunfa

12.9.1 Shenrunfa Corporation Information

12.9.2 Shenrunfa Business Overview

12.9.3 Shenrunfa 1-Bromopropane for Pharmaceutical Use Product Models, Descriptions and Specifications

12.9.4 Shenrunfa 1-Bromopropane for Pharmaceutical Use Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.9.5 Shenrunfa Recent Developments

12.10 Shouguang Fukang Pharmaceutical

12.10.1 Shouguang Fukang Pharmaceutical Corporation Information

12.10.2 Shouguang Fukang Pharmaceutical Business Overview

12.10.3 Shouguang Fukang Pharmaceutical 1-Bromopropane for Pharmaceutical Use Product Models, Descriptions and Specifications

12.10.4 Shouguang Fukang Pharmaceutical 1-Bromopropane for Pharmaceutical Use Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.10.5 Shouguang Fukang Pharmaceutical Recent Developments

12.11 Shouguang Luyuan Salt Chemical

12.11.1 Shouguang Luyuan Salt Chemical Corporation Information

12.11.2 Shouguang Luyuan Salt Chemical Business Overview

12.11.3 Shouguang Luyuan Salt Chemical 1-Bromopropane for Pharmaceutical Use Product Models, Descriptions and Specifications

12.11.4 Shouguang Luyuan Salt Chemical 1-Bromopropane for Pharmaceutical Use Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.11.5 Shouguang Luyuan Salt Chemical Recent Developments

12.12 Jinbiao Chemical

12.12.1 Jinbiao Chemical Corporation Information

12.12.2 Jinbiao Chemical Business Overview

12.12.3 Jinbiao Chemical 1-Bromopropane for Pharmaceutical Use Product Models, Descriptions and Specifications

12.12.4 Jinbiao Chemical 1-Bromopropane for Pharmaceutical Use Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.12.5 Jinbiao Chemical Recent Developments

12.13 Nova International

12.13.1 Nova International Corporation Information

12.13.2 Nova International Business Overview

12.13.3 Nova International 1-Bromopropane for Pharmaceutical Use Product Models, Descriptions and Specifications

12.13.4 Nova International 1-Bromopropane for Pharmaceutical Use Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.13.5 Nova International Recent Developments

12.14 Infinity Scientific

12.14.1 Infinity Scientific Corporation Information

12.14.2 Infinity Scientific Business Overview

12.14.3 Infinity Scientific 1-Bromopropane for Pharmaceutical Use Product Models, Descriptions and Specifications

12.14.4 Infinity Scientific 1-Bromopropane for Pharmaceutical Use Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.14.5 Infinity Scientific Recent Developments

12.15 Ataman Kimya

12.15.1 Ataman Kimya Corporation Information

12.15.2 Ataman Kimya Business Overview

12.15.3 Ataman Kimya 1-Bromopropane for Pharmaceutical Use Product Models, Descriptions and Specifications

12.15.4 Ataman Kimya 1-Bromopropane for Pharmaceutical Use Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.15.5 Ataman Kimya Recent Developments

13 Value Chain and Supply-Chain Analysis

13.1 1-Bromopropane for Pharmaceutical Use Industry Chain

13.2 1-Bromopropane for Pharmaceutical Use Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 1-Bromopropane for Pharmaceutical Use Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 1-Bromopropane for Pharmaceutical Use Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

14 1-Bromopropane for Pharmaceutical Use Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

15 Key Findings in the Global 1-Bromopropane for Pharmaceutical Use Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

FEATURED COMPANIES

Shouguang Fukang Pharmaceutical

Shouguang Luyuan Salt Chemical

List of Tables

Table 1. Global 1-Bromopropane for Pharmaceutical Use Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global 1-Bromopropane for Pharmaceutical Use Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global 1-Bromopropane for Pharmaceutical Use Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global 1-Bromopropane for Pharmaceutical Use Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global 1-Bromopropane for Pharmaceutical Use Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global 1-Bromopropane for Pharmaceutical Use Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)

Table 7. Global 1-Bromopropane for Pharmaceutical Use Sales by Region (2020-2025) & (Tons)

Table 8. Global 1-Bromopropane for Pharmaceutical Use Sales by Region (2026-2031) & (Tons)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global 1-Bromopropane for Pharmaceutical Use Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)

Table 11. Global 1-Bromopropane for Pharmaceutical Use Production by Region (2020-2025) & (Tons)

Table 12. Global 1-Bromopropane for Pharmaceutical Use Production by Region (2026-2031) & (Tons)

Table 13. Global 1-Bromopropane for Pharmaceutical Use Sales by Manufacturers (2020-2025) & (Tons)

Table 14. Global 1-Bromopropane for Pharmaceutical Use Sales Share by Manufacturers (2020-2025)

Table 15. Global 1-Bromopropane for Pharmaceutical Use Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 16. Global 1-Bromopropane for Pharmaceutical Use Revenue Market Share by Manufacturers (2020-2025)

Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 18. Global 1-Bromopropane for Pharmaceutical Use by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 1-Bromopropane for Pharmaceutical Use as of 2024)

Table 19. Global 1-Bromopropane for Pharmaceutical Use Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 20. Global 1-Bromopropane for Pharmaceutical Use Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)

Table 21. Key Manufacturers 1-Bromopropane for Pharmaceutical Use Manufacturing Base and Headquarters

Table 22. Global 1-Bromopropane for Pharmaceutical Use Market Concentration Ratio (CR5 and HHI)

Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 25. Global 1-Bromopropane for Pharmaceutical Use Sales by Type (2020-2025) & (Tons)

Table 26. Global 1-Bromopropane for Pharmaceutical Use Sales by Type (2026-2031) & (Tons)

Table 27. Global 1-Bromopropane for Pharmaceutical Use Revenue by Type (2020-2025) & (US$ Million)

Table 28. Global 1-Bromopropane for Pharmaceutical Use Revenue by Type (2026-2031) & (US$ Million)

Table 29. Global 1-Bromopropane for Pharmaceutical Use ASP by Type (2020-2031) & (US$/Ton)

Table 30. Technical Specifications by Key Product Type

Table 31. Global 1-Bromopropane for Pharmaceutical Use Sales by Application (2020-2025) & (Tons)

Table 32. Global 1-Bromopropane for Pharmaceutical Use Sales by Application (2026-2031) & (Tons)

Table 33. 1-Bromopropane for Pharmaceutical Use High-Growth Sectors Demand CAGR (2024-2031)

Table 34. Global 1-Bromopropane for Pharmaceutical Use Revenue by Application (2020-2025) & (US$ Million)

Table 35. Global 1-Bromopropane for Pharmaceutical Use Revenue by Application (2026-2031) & (US$ Million)

Table 36. Global 1-Bromopropane for Pharmaceutical Use ASP by Application (2020-2031) & (US$/Ton)

Table 37. Top Customers by Region

Table 38. Top Customers by Application

Table 39. North America 1-Bromopropane for Pharmaceutical Use Growth Accelerators and Market Barriers

Table 40. North America 1-Bromopropane for Pharmaceutical Use Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 41. North America 1-Bromopropane for Pharmaceutical Use Sales (Tons) by Country (2020 VS 2024 VS 2031)

Table 42. Europe 1-Bromopropane for Pharmaceutical Use Growth Accelerators and Market Barriers

Table 43. Europe 1-Bromopropane for Pharmaceutical Use Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. Europe 1-Bromopropane for Pharmaceutical Use Sales (Tons) by Country (2020 VS 2024 VS 2031)

Table 45. Asia-Pacific 1-Bromopropane for Pharmaceutical Use Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Asia-Pacific 1-Bromopropane for Pharmaceutical Use Sales (Tons) by Country (2020 VS 2024 VS 2031)

Table 47. Asia-Pacific 1-Bromopropane for Pharmaceutical Use Growth Accelerators and Market Barriers

Table 48. Southeast Asia 1-Bromopropane for Pharmaceutical Use Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 49. Central and South America 1-Bromopropane for Pharmaceutical Use Investment Opportunities and Key Challenges

Table 50. Central and South America 1-Bromopropane for Pharmaceutical Use Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 51. Middle East and Africa 1-Bromopropane for Pharmaceutical Use Investment Opportunities and Key Challenges

Table 52. Middle East and Africa 1-Bromopropane for Pharmaceutical Use Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 53. Albemarle Corporation Information

Table 54. Albemarle Description and Major Businesses

Table 55. Albemarle Product Models, Descriptions and Specifications

Table 56. Albemarle Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 57. Albemarle Sales Value Proportion by Product in 2024

Table 58. Albemarle Sales Value Proportion by Application in 2024

Table 59. Albemarle Sales Value Proportion by Geographic Area in 2024

Table 60. Albemarle 1-Bromopropane for Pharmaceutical Use SWOT Analysis

Table 61. Albemarle Recent Developments

Table 62. Chemtura Corporation Information

Table 63. Chemtura Description and Major Businesses

Table 64. Chemtura Product Models, Descriptions and Specifications

Table 65. Chemtura Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 66. Chemtura Sales Value Proportion by Product in 2024

Table 67. Chemtura Sales Value Proportion by Application in 2024

Table 68. Chemtura Sales Value Proportion by Geographic Area in 2024

Table 69. Chemtura 1-Bromopropane for Pharmaceutical Use SWOT Analysis

Table 70. Chemtura Recent Developments

Table 71. ICL Corporation Information

Table 72. ICL Description and Major Businesses

Table 73. ICL Product Models, Descriptions and Specifications

Table 74. ICL Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 75. ICL Sales Value Proportion by Product in 2024

Table 76. ICL Sales Value Proportion by Application in 2024

Table 77. ICL Sales Value Proportion by Geographic Area in 2024

Table 78. ICL 1-Bromopropane for Pharmaceutical Use SWOT Analysis

Table 79. ICL Recent Developments

Table 80. Weifang Longwei Corporation Information

Table 81. Weifang Longwei Description and Major Businesses

Table 82. Weifang Longwei Product Models, Descriptions and Specifications

Table 83. Weifang Longwei Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 84. Weifang Longwei Sales Value Proportion by Product in 2024

Table 85. Weifang Longwei Sales Value Proportion by Application in 2024

Table 86. Weifang Longwei Sales Value Proportion by Geographic Area in 2024

Table 87. Weifang Longwei 1-Bromopropane for Pharmaceutical Use SWOT Analysis

Table 88. Weifang Longwei Recent Developments

Table 89. Solaris Chemtech Corporation Information

Table 90. Solaris Chemtech Description and Major Businesses

Table 91. Solaris Chemtech Product Models, Descriptions and Specifications

Table 92. Solaris Chemtech Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. Solaris Chemtech Sales Value Proportion by Product in 2024

Table 94. Solaris Chemtech Sales Value Proportion by Application in 2024

Table 95. Solaris Chemtech Sales Value Proportion by Geographic Area in 2024

Table 96. Solaris Chemtech 1-Bromopropane for Pharmaceutical Use SWOT Analysis

Table 97. Solaris Chemtech Recent Developments

Table 98. Longsheng Chemical Corporation Information

Table 99. Longsheng Chemical Description and Major Businesses

Table 100. Longsheng Chemical Product Models, Descriptions and Specifications

Table 101. Longsheng Chemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 102. Longsheng Chemical Recent Developments

Table 103. Tongcheng Medical Corporation Information

Table 104. Tongcheng Medical Description and Major Businesses

Table 105. Tongcheng Medical Product Models, Descriptions and Specifications

Table 106. Tongcheng Medical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 107. Tongcheng Medical Recent Developments

Table 108. Shandong Moris Tech Corporation Information

Table 109. Shandong Moris Tech Description and Major Businesses

Table 110. Shandong Moris Tech Product Models, Descriptions and Specifications

Table 111. Shandong Moris Tech Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 112. Shandong Moris Tech Recent Developments

Table 113. Shenrunfa Corporation Information

Table 114. Shenrunfa Description and Major Businesses

Table 115. Shenrunfa Product Models, Descriptions and Specifications

Table 116. Shenrunfa Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 117. Shenrunfa Recent Developments

Table 118. Shouguang Fukang Pharmaceutical Corporation Information

Table 119. Shouguang Fukang Pharmaceutical Description and Major Businesses

Table 120. Shouguang Fukang Pharmaceutical Product Models, Descriptions and Specifications

Table 121. Shouguang Fukang Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 122. Shouguang Fukang Pharmaceutical Recent Developments

Table 123. Shouguang Luyuan Salt Chemical Corporation Information

Table 124. Shouguang Luyuan Salt Chemical Description and Major Businesses

Table 125. Shouguang Luyuan Salt Chemical Product Models, Descriptions and Specifications

Table 126. Shouguang Luyuan Salt Chemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 127. Shouguang Luyuan Salt Chemical Recent Developments

Table 128. Jinbiao Chemical Corporation Information

Table 129. Jinbiao Chemical Description and Major Businesses

Table 130. Jinbiao Chemical Product Models, Descriptions and Specifications

Table 131. Jinbiao Chemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 132. Jinbiao Chemical Recent Developments

Table 133. Nova International Corporation Information

Table 134. Nova International Description and Major Businesses

Table 135. Nova International Product Models, Descriptions and Specifications

Table 136. Nova International Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 137. Nova International Recent Developments

Table 138. Infinity Scientific Corporation Information

Table 139. Infinity Scientific Description and Major Businesses

Table 140. Infinity Scientific Product Models, Descriptions and Specifications

Table 141. Infinity Scientific Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 142. Infinity Scientific Recent Developments

Table 143. Ataman Kimya Corporation Information

Table 144. Ataman Kimya Description and Major Businesses

Table 145. Ataman Kimya Product Models, Descriptions and Specifications

Table 146. Ataman Kimya Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 147. Ataman Kimya Recent Developments

Table 148. Key Raw Materials Distribution

Table 149. Raw Materials Key Suppliers

Table 150. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 151. Milestones in Production Technology Evolution

Table 152. Distributors List

Table 153. Market Trends and Market Evolution

Table 154. Market Drivers and Opportunities

Table 155. Market Challenges, Risks, and Restraints

Table 156. Research Programs/Design for This Report

Table 157. Key Data Information from Secondary Sources

Table 158. Key Data Information from Primary Sources

List of Figures

Figure 1. 1-Bromopropane for Pharmaceutical Use Product Picture

Figure 2. Global 1-Bromopropane for Pharmaceutical Use Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. 99.0% Product Picture

Figure 4. 99.5% Product Picture

Figure 5. 99.9% Product Picture

Figure 6. Others Product Picture

Figure 7. Global 1-Bromopropane for Pharmaceutical Use Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 8. Intermediate Synthesis

Figure 9. Drug Synthesis

Figure 10. Others

Figure 11. 1-Bromopropane for Pharmaceutical Use Report Years Considered

Figure 12. Global 1-Bromopropane for Pharmaceutical Use Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global 1-Bromopropane for Pharmaceutical Use Revenue (2020-2031) & (US$ Million)

Figure 14. Global 1-Bromopropane for Pharmaceutical Use Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 15. Global 1-Bromopropane for Pharmaceutical Use Revenue Market Share by Region (2020-2031)

Figure 16. Global 1-Bromopropane for Pharmaceutical Use Sales (2020-2031) & (Tons)

Figure 17. Global 1-Bromopropane for Pharmaceutical Use Sales (CAGR) by Region (2020-2031) (Tons)

Figure 18. Global 1-Bromopropane for Pharmaceutical Use Sales Market Share by Region (2020-2031)

Figure 19. Global 1-Bromopropane for Pharmaceutical Use Capacity, Production and Utilization (2020-2031) & (Tons)

Figure 20. Global 1-Bromopropane for Pharmaceutical Use Production Trend by Region (2020-2031) (Tons)

Figure 21. Global 1-Bromopropane for Pharmaceutical Use Production Market Share by Region (2020-2031)

Figure 22. Production Capacity Enablers & Constraints

Figure 23. 1-Bromopropane for Pharmaceutical Use Production Growth Rate in North America (2020-2031) & (Tons)

Figure 24. 1-Bromopropane for Pharmaceutical Use Production Growth Rate in Europe (2020-2031) & (Tons)

Figure 25. 1-Bromopropane for Pharmaceutical Use Production Growth Rate in China (2020-2031) & (Tons)

Figure 26. 1-Bromopropane for Pharmaceutical Use Production Growth Rate in Japan (2020-2031) & (Tons)

Figure 27. Top 5 and Top 10 Manufacturers 1-Bromopropane for Pharmaceutical Use Sales Volume Market Share in 2024

Figure 28. Global 1-Bromopropane for Pharmaceutical Use Revenue Market Share Ranking (2024)

Figure 29. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 30. 99.0% Revenue Market Share by Manufacturer in 2024

Figure 31. 99.5% Revenue Market Share by Manufacturer in 2024

Figure 32. 99.9% Revenue Market Share by Manufacturer in 2024

Figure 33. Others Revenue Market Share by Manufacturer in 2024

Figure 34. Type Eight Revenue Market Share by Manufacturer in 2024

Figure 35. Type Nine Revenue Market Share by Manufacturer in 2024

Figure 36. Global 1-Bromopropane for Pharmaceutical Use Sales Market Share by Type (2020-2031)

Figure 37. Global 1-Bromopropane for Pharmaceutical Use Revenue Market Share by Type (2020-2031)

Figure 38. Global 1-Bromopropane for Pharmaceutical Use Sales Market Share by Application (2020-2031)

Figure 39. Global 1-Bromopropane for Pharmaceutical Use Revenue Market Share by Application (2020-2031)

Figure 40. North America 1-Bromopropane for Pharmaceutical Use Sales YoY (2020-2031) & (Tons)

Figure 41. North America 1-Bromopropane for Pharmaceutical Use Revenue YoY (2020-2031) & (US$ Million)

Figure 42. North America Top 5 Manufacturers 1-Bromopropane for Pharmaceutical Use Sales Revenue (US$ Million) in 2024

Figure 43. North America 1-Bromopropane for Pharmaceutical Use Sales Volume (Tons) by Type (2020- 2031)

Figure 44. North America 1-Bromopropane for Pharmaceutical Use Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 45. North America 1-Bromopropane for Pharmaceutical Use Sales Volume (Tons) by Application (2020-2031)

Figure 46. North America 1-Bromopropane for Pharmaceutical Use Sales Revenue (US$ Million) by Application (2020-2031)

Figure 47. US 1-Bromopropane for Pharmaceutical Use Revenue (2020-2031) & (US$ Million)

Figure 48. Canada 1-Bromopropane for Pharmaceutical Use Revenue (2020-2031) & (US$ Million)

Figure 49. Mexico 1-Bromopropane for Pharmaceutical Use Revenue (2020-2031) & (US$ Million)

Figure 50. Europe 1-Bromopropane for Pharmaceutical Use Sales YoY (2020-2031) & (Tons)

Figure 51. Europe 1-Bromopropane for Pharmaceutical Use Revenue YoY (2020-2031) & (US$ Million)

Figure 52. Europe Top 5 Manufacturers 1-Bromopropane for Pharmaceutical Use Sales Revenue (US$ Million) in 2024

Figure 53. Europe 1-Bromopropane for Pharmaceutical Use Sales Volume (Tons) by Type (2020-2031)

Figure 54. Europe 1-Bromopropane for Pharmaceutical Use Sales Revenue (US$ Million) by Type (2020-2031)

Figure 55. Europe 1-Bromopropane for Pharmaceutical Use Sales Volume (Tons) by Application (2020-2031)

Figure 56. Europe 1-Bromopropane for Pharmaceutical Use Sales Revenue (US$ Million) by Application (2020-2031)

Figure 57. Germany 1-Bromopropane for Pharmaceutical Use Revenue (2020-2031) & (US$ Million)

Figure 58. France 1-Bromopropane for Pharmaceutical Use Revenue (2020-2031) & (US$ Million)

Figure 59. U.K. 1-Bromopropane for Pharmaceutical Use Revenue (2020-2031) & (US$ Million)

Figure 60. Italy 1-Bromopropane for Pharmaceutical Use Revenue (2020-2031) & (US$ Million)

Figure 61. Russia 1-Bromopropane for Pharmaceutical Use Revenue (2020-2031) & (US$ Million)

Figure 62. Asia-Pacific 1-Bromopropane for Pharmaceutical Use Sales YoY (2020-2031) & (Tons)

Figure 63. Asia-Pacific 1-Bromopropane for Pharmaceutical Use Revenue YoY (2020-2031) & (US$ Million)

Figure 64. Asia-Pacific Top 8 Manufacturers 1-Bromopropane for Pharmaceutical Use Sales Revenue (US$ Million) in 2024

Figure 65. Asia-Pacific 1-Bromopropane for Pharmaceutical Use Sales Volume (Tons) by Type (2020- 2031)

Figure 66. Asia-Pacific 1-Bromopropane for Pharmaceutical Use Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 67. Asia-Pacific 1-Bromopropane for Pharmaceutical Use Sales Volume (Tons) by Application (2020-2031)

Figure 68. Asia-Pacific 1-Bromopropane for Pharmaceutical Use Sales Revenue (US$ Million) by Application (2020-2031)

Figure 69. Indonesia 1-Bromopropane for Pharmaceutical Use Revenue (2020-2031) & (US$ Million)

Figure 70. Japan 1-Bromopropane for Pharmaceutical Use Revenue (2020-2031) & (US$ Million)

Figure 71. South Korea 1-Bromopropane for Pharmaceutical Use Revenue (2020-2031) & (US$ Million)

Figure 72. China Taiwan 1-Bromopropane for Pharmaceutical Use Revenue (2020-2031) & (US$ Million)

Figure 73. India 1-Bromopropane for Pharmaceutical Use Revenue (2020-2031) & (US$ Million)

Figure 74. Central and South America 1-Bromopropane for Pharmaceutical Use Sales YoY (2020-2031) & (Tons)

Figure 75. Central and South America 1-Bromopropane for Pharmaceutical Use Revenue YoY (2020-2031) & (US$ Million)

Figure 76. Central and South America Top 5 Manufacturers 1-Bromopropane for Pharmaceutical Use Sales Revenue (US$ Million) in 2024

Figure 77. Central and South America 1-Bromopropane for Pharmaceutical Use Sales Volume (Tons) by Type (2021-2031)

Figure 78. Central and South America 1-Bromopropane for Pharmaceutical Use Sales Revenue (US$ Million) by Type (2020-2031)

Figure 79. Central and South America 1-Bromopropane for Pharmaceutical Use Sales Volume (Tons) by Application (2020-2031)

Figure 80. Central and South America 1-Bromopropane for Pharmaceutical Use Sales Revenue (US$ Million) by Application (2020-2031)

Figure 81. Brazil 1-Bromopropane for Pharmaceutical Use Revenue (2020-2025) & (US$ Million)

Figure 82. Argentina 1-Bromopropane for Pharmaceutical Use Revenue (2020-2025) & (US$ Million)

Figure 83. Middle East, and Africa 1-Bromopropane for Pharmaceutical Use Sales YoY (2020-2031) & (Tons)

Figure 84. Middle East and Africa 1-Bromopropane for Pharmaceutical Use Revenue YoY (2020-2031) & (US$ Million)

Figure 85. Middle East and Africa Top 5 Manufacturers 1-Bromopropane for Pharmaceutical Use Sales Revenue (US$ Million) in 2024

Figure 86. Middle East and Africa 1-Bromopropane for Pharmaceutical Use Sales Volume (Tons) by Type (2021-2031)

Figure 87. South America 1-Bromopropane for Pharmaceutical Use Sales Revenue (US$ Million) by Type (2020-2031)

Figure 88. Middle East and Africa 1-Bromopropane for Pharmaceutical Use Sales Volume (Tons) by Application (2020-2031)

Figure 89. Middle East and Africa 1-Bromopropane for Pharmaceutical Use Sales Revenue (US$ Million) by Application (2020-2031)

Figure 90. GCC Countries 1-Bromopropane for Pharmaceutical Use Revenue (2020-2025) & (US$ Million)

Figure 91. Turkey 1-Bromopropane for Pharmaceutical Use Revenue (2020-2025) & (US$ Million)

Figure 92. Egypt 1-Bromopropane for Pharmaceutical Use Revenue (2020-2025) & (US$ Million)

Figure 93. South Africa 1-Bromopropane for Pharmaceutical Use Revenue (2020-2025) & (US$ Million)

Figure 94. 1-Bromopropane for Pharmaceutical Use Industry Chain Mapping

Figure 95. Regional 1-Bromopropane for Pharmaceutical Use Manufacturing Base Distribution (%)

Figure 96. 1-Bromopropane for Pharmaceutical Use Production Process

Figure 97. Regional 1-Bromopropane for Pharmaceutical Use Production Cost Structure

Figure 98. Channels of Distribution (Direct Vs Distribution)

Figure 99. Bottom-up and Top-down Approaches for This Report

Figure 100. Data Triangulation

Figure 101. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions